Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug ...

A new study published in AI in Precision Oncology examines the ability of large language models (LLMs) to rapidly extract ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Family and gender-based violence can have lasting impacts on physical and mental health and be at the root of public health issues, such as substance use, suicide and self-harm, anxiety, depression ...

Xsolla, a leading global video game commerce company, announces the launch of the Xsolla Publishing Suite, an all-in-one direct-to-consumer (D2C) solution designed to help developers sell and ...

Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

After a promising feasibility study showing the potential of its natural language processing models, MSK has ambitions to use them in patient care.